Donald Steven Furman Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 days, 22 hours ago
Donald Steven Furman has an estimated net worth of at least $22.2 million*, as of Nov. 13, 2024. They own 1.5 million shares of ALHC stock. They have sold 103,006 shares of ALHC stock since 2021, for an estimated $2.0 million.
Donald Steven Furman $ALHC SEC Form 4 Insider Trading
Donald Steven Furman has filed a total of 2 insider trades in $ALHC since 2021. Their most recent trade was a sale of 3,006 shares, made on Mar 31, 2022. Their largest trade was a sale of 100,000 shares, made on Nov 23, 2021. We estimate that they now own 1.5 million shares of $ALHC, worth an estimated $20.1 million.
Insider Trading at $ALHC
There have been a total of 193 insider trades reported at $ALHC since 2021, with 203,000 shares purchased and 48.9 million shares sold. The most active insider traders in $ALHC stock have been Robert Thomas Freeman, Dawn Christine Maroney, and John E Kao. The most recent trade was a sale of 30,000 shares reported by Dawn Christine Maroney (President, Markets), made on Nov 15, 2024.
History of Insider Stock Trades by Donald Steven Furman
$ALHC Executives and Stock Owners with Insider Trades
-
Robert Thomas Freeman, Chief Financial Officer
-
Dawn Christine Maroney, President, Markets
-
John E Kao, Chief Executive Officer
-
Dinesh M. Kumar, Chief Med & Operating Officer
-
Christopher J Joyce, Chief Legal and Admin. Officer
-
Hakan Kardes, Chief Experience Officer
-
Dinesh M. Kumar, Chief Medical Officer
-
Joseph S Konowiecki, Chairman of the Board
-
Richard A. Cross, SVP, General Counsel
-
Robert L. Scavo, Chief Information Officer
-
Donald Steven Furman, Chief Clinical Officer
-
Hyong Kim, Chief Medical Officer
-
Rajesh Shrestha, Pres., New Markets & CBO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.